Final Mile Enterprises, Optimus Finance, Shukra Prescription drugs, Softrak Enterprise Funding to commerce ex-split in the present day.

Numerous shares, resembling Final Mile Enterprises, Optimus Finance, Shukra Prescription drugs, Softrak Enterprise Funding will commerce ex-split in the present day. Buyers ought to monitor these company actions intently, as they will affect inventory costs and buying and selling volumes. Every of those firms has carried out a share break up, lowering the face worth from ₹10 to Re 1, which makes shares extra accessible for retail buyers and enhances market liquidity.

The document date for the sub-division of fairness shares, as authorized by the shareholders, is ready for March 21, 2025. Based on the T+1 settlement course of, buyers who bought shares of Final Mile Enterprises, Optimus Finance, Shukra Prescription drugs, and Softrak Enterprise Funding the day earlier than the document date can have their names included among the many eligible shareholders to learn from the inventory break up.

Inventory Break up Particulars

Final Mile Enterprises

Establishing the allocation of fairness shareholders for the rationale of subdividing or splitting the present fairness shares of the corporate, through which 1 fairness share with a face worth of ₹10 every, totally paid-up, will likely be divided into 10 fairness shares with a face worth of ₹1 every, totally paid-up.

Based on Trendlyne, Final Mile Enterprises has executed a face worth break up as soon as since March 21, 2025. In 2025, Final Mile Enterprises final decreased the face worth of its shares from ₹10 to Re 1. The shares have been buying and selling on an ex-split foundation ranging from March 21, 2025.

Optimus Finance

Based on the submitting, the entitlement/eligibility of fairness shareholders will likely be assessed for the subdivision/break up of 1 current fairness share with a face worth of ₹10 every that’s totally paid up into ten totally paid-up fairness shares with a face worth of Re 1 every.

Shukra Prescription drugs

Based on the submitting, the fairness shares of Re 1 every for the corporate will likely be legitimate for trades executed on and after the ex-date, which is March 21. Shukra Prescription drugs has undertaken one break up of the face worth since March 21, 2025. In 2025, Shukra Prescription drugs final decreased the face worth of its shares from ₹10 to Re 1. The shares have been buying and selling on an ex-split foundation since March 21, 2025.

Softrak Enterprise Funding

Based on the submitting, the fairness shares have been subdivided from ₹10 to Re 1. Primarily based on Trendlyne knowledge, Softrak Enterprise Funding Ltd. has undergone a break up of its face worth as soon as since March 21, 2025. The newest break up occurred in 2025, when the corporate decreased the face worth of its shares from ₹10 to Re 1. The shares have been buying and selling on an ex-split foundation since March 21, 2025.

Disclaimer: The views and suggestions above are these of particular person analysts, consultants and broking firms, not of Mint. We advise buyers to test with licensed consultants earlier than making any funding choice.